Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  NATIONAL STOCK EXCHANGE OF INDIA  >  Piramal Enterprises Ltd    PEL   INE140A01024

 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote National Stock Exchange O…
07/17/2017 07/18/2017 07/19/2017 07/20/2017 07/21/2017 Date
2922.1(c) 2930(c) 2948(c) 2934.2(c) 2910.7 Last
139 218 152 913 101 538 99 401 81 123 Volume
+0.62% +0.27% +0.61% -0.47% -0.80% Change
More quotes
Financials ( INR)
Sales 2018 108 453 M
EBIT 2018 38 138 M
Net income 2018 -
Debt 2018 -
Yield 2018 1,06%
Sales 2019 132 436 M
EBIT 2019 46 210 M
Net income 2019 -
Debt 2019 -
Yield 2019 1,32%
P/E ratio 2018 -
P/E ratio 2019
Capi. / Sales2018 4,64x
Capi. / Sales2019 3,80x
Capitalization 503 548 M
More Financials
Company
Piramal Enterprises Ltd. engages in pharmaceutical business with its research and development activities.The company operates through the following segments: Piramal Healthcare, Piramal Capital and Information Management.The Piramal Healthcare segment operates through the following divisions:... 
Sector
Pharmaceuticals
Calendar
08/01Earnings Release
More about the company
Latest news on PIRAMAL ENTERPRISES LTD
07/21 PIRAMAL HEALTHCARE LIMITED : ex-dividend day for annual dividend
07/19 PIRAMAL ENTERPRISES : Wins Gold at LACP Vision Awards
07/12 PIRAMAL ENTERPRISES : To expand pharma presence in us, europe
07/10 INVESTMENT IN SHRIRAM STRATEGIC, WON : Piramal
07/08 Regulatory hurdles may take sheen off idfc-shriram merger
07/08 Piramal enterprises' bets on shriram group pay off
07/07 PIRAMAL ENTERPRISES : ACME Solar receives $108m funding injection from Piramal
07/07 PIRAMAL ENTERPRISES : Shifting focus to non-conventional energy
07/07 PIRAMAL ENTERPRISES : Ajay piramal scouting for an nbfc
07/06 PIRAMAL ENTERPRISES : extends Rs 700 crore credit line to solar energy
More news
Sector news : Pharmaceuticals - NEC
07/21 FTSE, sheltered from euro strength, has best week since May
07/21DJGLAXOSMITHKLINE : FDA Approves Injectable Form Of Glaxo's Benlysta
07/21 GlaxoSmithKline's new CEO prepares to trim drug pipeline
07/21 AstraZeneca CEO reassures staff, aims to be at September cancer meet
07/20 Abbott profit forecast gets a lift from St. Jude integration
More sector news : Pharmaceuticals - NEC
Latest Tweets
06/27#Piramal Enterprises to raise up to Rs 500 crore through issuance of NCDs on ..
2
06/27Piramal Enterprises to raise up to Rs 500 cr via NCDs  
06/27Piramal Enterprises to raise up to Rs500 crore via NCDs
1
06/27Piramal Enterprises to raise up to Rs 500 crore via non-convertible #debentur.. 
06/23Piramal Enterprises board gives nod to raise up to Rs 125 crore
1
More tweets
Qtime:46
Chart PIRAMAL ENTERPRISES LTD
Duration : Period :
Piramal Enterprises Ltd Technical Analysis Chart | PEL | INE140A01024 | 4-Traders
Technical analysis trends PIRAMAL ENTERPRISES LTD
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 3
Average target price 2 947  INR
Spread / Average Target 0,99%
Managers
NameTitle
Ajay Gopikisan Piramal Chairman
Vijay Kantilal Shah Chief Operating Officer & Executive Director
Swati Ajay Piramal Vice Chairman
Subramanian V. Ramadorai Independent Non-Executive Director
Narayanan Vaghul Independent Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
PIRAMAL ENTERPRISES LTD79.67%7 829
JOHNSON & JOHNSON17.45%364 503
ROCHE HOLDING LTD.4.90%221 492
NOVARTIS8.37%220 936
PFIZER3.08%199 378
MERCK AND COMPANY6.39%171 303